iBio (IBIO) Income from Continuing Operations (2016 - 2025)

iBio (IBIO) has disclosed Income from Continuing Operations for 16 consecutive years, with 8993000.0 as the latest value for Q4 2025.

  • Quarterly Income from Continuing Operations fell 106.07% to 8993000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 24737000.0 through Dec 2025, down 62.38% year-over-year, with the annual reading at 18377000.0 for FY2025, 11.76% down from the prior year.
  • Income from Continuing Operations for Q4 2025 was 8993000.0 at iBio, down from 5720000.0 in the prior quarter.
  • The five-year high for Income from Continuing Operations was 3246000.0 in Q2 2024, with the low at 10563000.0 in Q4 2022.
  • Average Income from Continuing Operations over 5 years is 6331500.0, with a median of 5758500.0 recorded in 2021.
  • The sharpest move saw Income from Continuing Operations plummeted 185.09% in 2021, then surged 57.51% in 2023.
  • Over 5 years, Income from Continuing Operations stood at 7196000.0 in 2021, then plummeted by 46.79% to 10563000.0 in 2022, then soared by 57.51% to 4488000.0 in 2023, then increased by 2.76% to 4364000.0 in 2024, then crashed by 106.07% to 8993000.0 in 2025.
  • According to Business Quant data, Income from Continuing Operations over the past three periods came in at 8993000.0, 5720000.0, and 5163000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.